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PrP (small gold particles) is found in endocytic structures with caveolin-1 (large particles).
in late endosomes and lysosomes. The group now shows that, unlike most internalized proteins, which use the typical clathrindependent endocytosis pathway, PrP finds its way to lysosomes through an endosomal compartment that lacks clathrin but contains caveolin-1.
The results contrast another study that reported colocalization of PrP and clathrin in vesicles. But the cryoimmunogold EM method used by Peters et al. allows for higher resolution of the vesicles and their contents. Simian virus 40 particles were also shown to be taken in through caveolin-containing, clathrinnegative structures that are connected to an endocytic vacuole (collectively termed caveosomes). Although the PrP-containing
Stop and go L1CAM
mobile adhesion receptor allows a cell to migrate, whereas a stationary version of the same receptor keeps it in place, based on results from Gil et al. on page 719 .
The immunoglobulin family member L1CAM promotes both growth cone extension in the developing central nervous system and cell adhesionmediated maintenance of axon bundles in mature neurons. How the same adhesion molecule regulates these disparate functions is not clear, particularly since the L1 family does not undergo the class switching (from adhesion-promoter to migrationpromoter) that seems to be common in integrins.
Rather than changing receptor types, L1CAM switches its own kinetic behavior to modulate cell movements. Stationary L1CAM, which may be associated with adhesion, was found to depend on ankyrin to stay in place.
A vesicles lacked virus, the two atypical endocytic structures may be one and the same. If so, this EM study is the first ultrastructural view of caveosomes, which contain raft domains that are preferred by membrane-bound PrP.
Both the low pH and high concentration of raft lipids in the caveolin-containing compartment may favor PrP conversion to the pathogenic form. Therefore, the group expects that caveolin knock-out mice should be less susceptible to oral prions, but they await use of these mice to test their theory. In the meantime, they are testing whether drugs such as statins, which interfere with cholesterol-rich raft domains, might slow prion disease progression. retrograde receptor movement seen on the upper surface of the cell is thought to reflect the direction of traction forces generated on the lower surface. In support of this theory, the authors found that peptide-mediated release of stationary L1CAM produced greater neurite extension through growth cone migration.
During development, neurons may switch from migration in the growth cone to adhesion in the axon and synapse by increasingly dephosphorylating L1CAM (and therefore promoting ankyrin binding). L1CAM-ankyrin interactions may also be dynamically regulated in the growth cone to suppress traction forces that are incorrectly oriented. Peptides that interfere with L1CAM-ankyrin binding may one day be used therapeutically to awaken the retrograde movement of stationary L1CAM receptors in injured nerves.
